Noninvasive estimation of hepatic steatosis using plain CT vs. Chemical‐shift MR imaging: Significance for living donors
暂无分享,去创建一个
Hiroshi Honda | Masakazu Hirakawa | Yasuhiro Ushijima | Hiroyuki Irie | Kengo Yoshimitsu | Tsuyoshi Tajima | Kousei Ishigami | Akinobu Taketomi | H. Honda | Y. Ushijima | H. Irie | Tomomi Yamada | M. Nakamuta | T. Tajima | K. Ishigami | A. Taketomi | K. Yoshimitsu | M. Hirakawa | Makoto Nakamuta | Yousuke Kuroda | Tomomi Yamada | Y. Kuroda
[1] B. Geramizadeh,et al. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation. , 2007, Transplantation proceedings.
[2] H. Honda,et al. Papillary renal carcinoma: Diagnostic approach by chemical shift gradient‐echo and echo‐planar MR imaging , 2006, Journal of magnetic resonance imaging : JMRI.
[3] H. Hussain,et al. Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. , 2005, Radiology.
[4] H. Bonkovsky,et al. Iron in nonhemochromatotic liver disorders. , 2005, Seminars in liver disease.
[5] G. Ramm,et al. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. , 2005, Seminars in liver disease.
[6] Y. Maehara,et al. Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation , 2005, Transplantation.
[7] J. Briceño,et al. Assignment of steatotic livers by the Mayo model for end‐stage liver disease , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[8] H. Honda,et al. Comparison of Test-Injection Method and Fixed-Time Method for Depiction of Hepatocellular Carcinoma Using Dynamic Steady-State Free Precession Magnetic Resonance Imaging , 2004, Journal of computer assisted tomography.
[9] Michael Abecassis,et al. Dual‐echo, chemical shift gradient‐echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] T. Kim,et al. Evaluation of the Hepatic Artery in Potential Donors for Living Donor Liver Transplantation by Computed Tomography Angiography Using Multidetector-row Computed Tomography: Comparison of Volume Rendering and Maximum Intensity Projection Techniques , 2003, Journal of computer assisted tomography.
[11] M. Abecassis,et al. Liver biopsy in living donors , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] C. Ryan,et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[14] P. Ros,et al. MR imaging in chronic hepatitis and cirrhosis. , 2002, Seminars in ultrasound, CT, and MR.
[15] Chao-Long Chen,et al. Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. , 2001, Transplantation.
[16] S. Kitano,et al. ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1 , 2001, Transplantation.
[17] M. Abecassis,et al. Body mass index as a predictor of hepatic steatosis in living liver donors , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] Y. Yamashita,et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. , 2001, Radiology.
[19] E. Siegelman,et al. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. , 2001, AJR. American journal of roentgenology.
[20] H. Rüdiger,et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver , 2000, Hepatology.
[21] R. Fisher,et al. Single‐center analysis of the first 40 adult‐to‐adult living donor liver transplants using the right lobe , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] C. Avellini,et al. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. , 2000, American journal of clinical pathology.
[23] S. Kitano,et al. PP-1209 NOVEL ASSESSMENT OF DONOR STEATOSIS FOR LIVER TRANSPLANTATION , 2000 .
[24] H. Honda,et al. MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient‐echo imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[25] E K Outwater,et al. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.
[26] G. Mancia,et al. Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations , 1998, Hepatology.
[27] Miguel Angel García Ureña,et al. Hepatic Steatosis in Liver Transplant Donors: Common Feature of Donor Population? , 1998, World Journal of Surgery.
[28] J. Ludwig,et al. Hepatic steatosis as a potential risk factor for major hepatic resection , 1998, Journal of Gastrointestinal Surgery.
[29] L Dalla Palma,et al. Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.
[30] N. Ryley,et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM , 1997, International Journal of Obesity.
[31] K. Batts,et al. Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.
[32] N. Rofsky,et al. CT and MRI of diffuse liver disease. , 1995, Seminars in ultrasound, CT, and MR.
[33] M. Stegall,et al. Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.
[34] C. Compton,et al. Diagnosis of fatty liver with MR imaging , 1992, Journal of magnetic resonance imaging : JMRI.
[35] S. Knechtle,et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.
[36] R. Buxton,et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. , 1991, AJR. American journal of roentgenology.
[37] J. Ellis,et al. Focal fatty infiltration of the liver: demonstration by magnetic resonance imaging. , 1984, AJR. American journal of roentgenology.
[38] I. Suramo,et al. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. , 1983, Scandinavian journal of gastroenterology.
[39] James Sayre,et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. , 2004, Radiology.
[40] J. Hogg. Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.
[41] N. L. Johnson,et al. Multivariate Analysis , 1958, Nature.